ArticleJournal of advanced pharmaceutical technology & research
Impact of Vitamin D status on age at menopause: A prospective cohort study.
Article in Journal of advanced pharmaceutical technology & research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Is Follicle-Stimulating Hormone (FSH) Misnamed? Rethinking Its Role in Menopause as a Systemic Regulator of Bone, Brain, Metabolism, and Aging.Journal of clinical medicine · 2026Review
- Association Between Vitamin D Status, Metabolic Syndrome, and Menopausal Type: A Comparative Observational Study in Women with Early and Physiological Menopause.Biomedicines · 2026Article
- Vitamin D Status and Reproductive Hormonal Profiles in Early Versus Physiological Menopause: A Comparative Observational Study.Biomedicines · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Calcium levels, closely tied to Vitamin D, significantly impact female health. However, the link between Vitamin D and menopause, its onset, and symptom severity remains unclear. This study aimed to examine the impact of Vitamin D supplementation on the age at menopause, menopausal symptoms, hormonal levels, and bone density in women. A 2-year prospective study of 100 menopausal women, grouped by Vitamin D levels (<20 ng/mL and >30 ng/mL), analyzed menopausal age, symptoms, hormone levels, and bone density. The results show that the women with vitamin D levels below 20 ng/mL had later menopause, more severe symptoms, lower estrogen, higher follicle-stimulating hormone, poorer bone density, and reduced quality of life than those with levels above 30 ng/mL, with all differences statistically significant (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.